Skip to content

AnGes Inc Sustainability Reports

AnGes, Inc. focuses on the research, development, and commercialization of gene-based medicines, nucleic acid drugs, and diagnostic testing services for rare diseases.

Sector: Manufacturing

Country: Japan

Exchange: Tokyo Stock Exchange

LEI: 529900HERUBGP6BTMO45

FIGI: BBG001SL2FT3

1 reports from 2025 to 2025